CONCENTRATION - 1590 Anuncios

Tuesday 29 July 2025

Cantidad : 10mg*10via - Precio : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday 29 July 2025

Cantidad : 5mg*10vial - Precio : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Saturday 26 July 2025

Cantidad : 5mg*10vial - Precio : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday 25 July 2025

Linaclotide is a guanylate cyclase-C receptor agonist (GCCA) with both visceral analgesic effects and endocrine activity. Both linaclotide and its active metabolite bind to guanylate cyclase-C (GC-C) receptors on the luminal surface of small intestinal epithelial tubules. In animal models...

Friday 25 July 2025

Cantidad : 1kg; 25kg;

Ethanol is a type of and the main component of wine. It is also commonly known as and liquor. It is neutral. Ethanol is flammable and is a commonly used fuel, solvent and disinfectant. It is also used in organic synthesis. Industrial contains a small amount of toxic methanol. Medical...

Friday 25 July 2025

Terlipressin is a new type of synthetic long-acting vasopressin preparation, belonging to a precursor drug, itself inactive, in vivo by the action of aminopeptidase, to remove its N-terminal 3 glycyl residues, slowly “release” the active lysine pressin. It is this “slow release”...

Friday 25 July 2025

Cantidad : 60mg*10via - Precio : USD 650

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday 25 July 2025

Cantidad : 50mg*10via - Precio : USD 550

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday 25 July 2025

Cantidad : 40mg*10via - Precio : USD 450

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday 25 July 2025

Cantidad : 30mg*10via - Precio : USD 360

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday 25 July 2025

Cantidad : 20mg*10via - Precio : USD 300

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday 25 July 2025

Cantidad : 15mg*10via - Precio : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday 25 July 2025

Cantidad : 10mg*10via - Precio : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday 25 July 2025

Cantidad : 5mg*10vial - Precio : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday 22 July 2025

Octreotide is a digestive system drug, a synthetic octapeptide cyclic compound, a homologue of natural growth inhibitor, with the pharmacological activity of natural growth inhibitor (Somatostatin), and has a long-lasting effect (the half-life of this product is 1.5 hours, while the...)

Tuesday 22 July 2025

Linaclotide is a guanylate cyclase-C receptor agonist (GCCA) with both visceral analgesic effects and endocrine activity. Both linaclotide and its active metabolite bind to guanylate cyclase-C (GC-C) receptors on the luminal surface of small intestinal epithelial tubules. In animal models...

Saturday 19 July 2025

Terlipressin is a new type of synthetic long-acting vasopressin preparation, belonging to a precursor drug, itself inactive, in vivo by the action of aminopeptidase, to remove its N-terminal 3 glycyl residues, slowly “release” the active lysine pressin. It is this “slow release” mechanism...

Saturday 19 July 2025

Goserelin is a gonadorelin analog with similar effects, and was approved for marketing in France in 1987. Goserelin is an analog of luteinizing hormone-releasing hormone, long-term use of this product can inhibit the synthesis of pituitary luteinizing hormone, thus causing a decline...

Friday 18 July 2025

Tianeptine Sodium is a drug used for treating major depressive episodes (mild, moderate, or severe). It has structural similarities to the tricyclic antidepressants, but it has different pharmacological properties. Tianeptine is a selective serotonin reuptake enhancer (SSRE), opposite...

Friday 18 July 2025

Potassium iodide (KI) is a white, crystalline salt that is highly soluble in water. Its ability to form complexes with silver ions makes it valuable in developing photographs, enhancing image quality. Furthermore, potassium iodide serves as a reagent in analytical chemistry for iodometric...

Thursday 17 July 2025

Tianeptine Sodium is a drug used for treating major depressive episodes (mild, moderate, or severe). It has structural similarities to the tricyclic antidepressants, but it has different pharmacological properties. Tianeptine is a selective serotonin reuptake enhancer (SSRE), opposite...

Thursday 17 July 2025

Potassium iodide (KI) is a white, crystalline salt that is highly soluble in water. Its ability to form complexes with silver ions makes it valuable in developing photographs, enhancing image quality. Furthermore, potassium iodide serves as a reagent in analytical chemistry for iodometric...

Thursday 17 July 2025

Octreotide is a digestive system drug, a synthetic octapeptide cyclic compound, a homologue of natural growth inhibitor, with the pharmacological activity of natural growth inhibitor (Somatostatin), and has a long-lasting effect (the half-life of this product is 1.5 hours, while...)

Thursday 17 July 2025

Linaclotide is a guanylate cyclase-C receptor agonist (GCCA) with both visceral analgesic effects and endocrine activity. Both linaclotide and its active metabolite bind to guanylate cyclase-C (GC-C) receptors on the luminal surface of small intestinal epithelial tubules. In animal models...

Thursday 17 July 2025

Terlipressin is a new type of synthetic long-acting vasopressin preparation, belonging to a precursor drug, itself inactive, in vivo by the action of aminopeptidase, to remove its N-terminal 3 glycyl residues, slowly “release” the active lysine pressin. It is this “slow release”...

Wednesday 09 July 2025

EPO has a wide range of clinical applications, and the anemic treatment of kidney and cancer tumors is the first. Chemicalbook detection of EPO level in serum of patients with cancer anemia, EPO concentration detection in anemia patients, EPO detection in serum of cancer patients...

Wednesday 09 July 2025

Selank is a synthetic derivative of the tetrapeptide tuftsin that contains a proline-glycine-proline sequence at the C-terminus and has anxiolytic and anti-inflammatory activities. It increases the amplitude and discharge rate of inhibitory postsynaptic currents of neurons in the...

Wednesday 09 July 2025

Copper tripeptide, also known as [N2-(N-Glycyl-L-histidyl)-L-lysinato(2-) ]copper or GHK-Cu, is a naturally occurring tripeptide. It was first isolated from human plasma but can be found in saliva and urine. During wound healing, it may be freed from existing extracellular proteins...

Wednesday 09 July 2025

Semax is a synthetic analogue of the adrenocorticotropic hormone, a hormone responsible for the production of cortisol which in turn regulates glucose and lipid metabolism and helps to maintain blood pressure. In the hippocampus, Semax rapidly elevates the levels of brain-derived...

Wednesday 09 July 2025

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...